While care plans are highly personalised for each individual, all new diabetes patients at GluCare receive a starter kit during their first in-clinic visit. This includes a wearable “band” that measures heart rate and heart rate variability, respiration rate, physical activity, skin temperature, and sleep patterns; a wearable Continuous Glucose Monitor or Blood Glucose Device; and may include a smart Blood Pressure Monitor; and smart Weight Scale. This kit of connected devices collects and collates real-time data in a proprietary phone app that, combined with self-reported factors such as photos of meals and well-being questionnaires, are sent back in real-time to an AI and machine learning platform.
While Remote Continuous Data Monitoring is a totally new concept, and DTx is relatively new within the medical sector, data from studies on their limited application in the United States – measuring blood glucose only – suggest great potential for improved diabetes patient outcomes, including a 21% reduction in death and a 43% reduction in peripheral vascular disease.
In the same study, intermittent tracking of only blood glucose with a DTx platform resulted in a total cost reduction on average of 22%, driven primarily by reduction in unnecessary patient visits (24.6%) and diabetes related medical costs (10.7%).
【MORE】